We have previously described several potent dual inhibitors of Plasmodium falciparum (Pf) growth characterized by the presence of statin, a β-hydroxyl amino acid able to inhibit parasite’s plasmepsins (PLM). While investigating the mechanism of action of these inhibitors new compounds deprived of statin were synthetized which lost the ability to inhibit PLM, but retained a significant Pf growth inhibition. Further structural simplifications showed that the inhibition of Pf viability was to ascribe to a new pharmacophore never described before as antimalarial
Discovery of oxybisbenzoylamides as a new class of antimalarial agents / A. Pancotti, S. Parapini, M. Dell'Agli, L. Gambini, C. Galli, E. Sangiovanni, N. Basilico, E. Bosisio, D. Taramelli, S. Romeo. - In: MEDCHEMCOMM. - ISSN 2040-2503. - 6:6(2015 Jun 01), pp. 1173-1177. [10.1039/C5MD00115C]
Discovery of oxybisbenzoylamides as a new class of antimalarial agents
A. Pancotti;S. Parapini;M. Dell'Agli;L. Gambini;C. Galli;E. Sangiovanni;N. Basilico;E. Bosisio;D. Taramelli;S. Romeo
2015
Abstract
We have previously described several potent dual inhibitors of Plasmodium falciparum (Pf) growth characterized by the presence of statin, a β-hydroxyl amino acid able to inhibit parasite’s plasmepsins (PLM). While investigating the mechanism of action of these inhibitors new compounds deprived of statin were synthetized which lost the ability to inhibit PLM, but retained a significant Pf growth inhibition. Further structural simplifications showed that the inhibition of Pf viability was to ascribe to a new pharmacophore never described before as antimalarialFile | Dimensione | Formato | |
---|---|---|---|
C5MD00115C.pdf
accesso aperto
Tipologia:
Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione
645.6 kB
Formato
Adobe PDF
|
645.6 kB | Adobe PDF | Visualizza/Apri |
c5md00115c.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
268.29 kB
Formato
Adobe PDF
|
268.29 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.